Publications by authors named "Michaela Feodoroff"

Claim this Profile
E
Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapy.
Salvatore Russo, Yvonne Giannoula, Sara Feola, Justin Cerioni, Firas Hamdan, Michaela Feodoroff

J Immunother Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional screening identifies kinesin spindle protein inhibitor filanesib as a potential treatment option for hepatoblastoma.
Ruth Nousiainen, Katja Eloranta, Jani Saarela, Antti Hassinen, Tamara J Luck, Michaela J Feodoroff

NPJ Precis Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses.
Michaela Feodoroff, Firas Hamdan, Gabriella Antignani, Sara Feola, Manlio Fusciello

Oncoimmunology· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome.
Mariia S Bogacheva, Suvi Kuivanen, Swapnil Potdar, Antti Hassinen, Sini Huuskonen, Michaela Feodoroff

Antiviral Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors.
Sara Feola, Firas Hamdan, Salvatore Russo, Jacopo Chiaro, Manlio Fusciello, Michaela Feodoroff

J Immunother Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy.
Salvatore Russo, Sara Feola, Michaela Feodoroff, Jacopo Chiaro, Gabriella Antignani

Mol Ther Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors.
Jacopo Chiaro, Gabriella Antignani, Sara Feola, Michaela Feodoroff, Beatriz Martins

Nat Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets.
Silvia Angori, Amir Banaei-Esfahani, Katharina Mühlbauer, Hella A Bolck, Abdullah Kahraman, Michaela Feodoroff

Eur Urol Focus· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two supporting matrices for patient-derived cancer cells in 3D drug sensitivity and resistance testing assay (3D-DSRT).
Michaela Feodoroff, Piia Mikkonen, Laura Turunen, Antti Hassinen, Lauri Paasonen

SLAS Discov· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for 3D drug sensitivity and resistance testing of patient-derived cancer cells in 384-well plates.
Michaela Feodoroff, Piia Mikkonen, Mariliina Arjama, Astrid Murumägi, Olli Kallioniemi

SLAS Discov· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses.
Firas Hamdan, Michaela Feodoroff, Salvatore Russo, Manlio Fusciello, Sara Feola

Mol Ther Oncolytics· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine.
Sara Feola, Salvatore Russo, Beatriz Martins, Alessandra Lopes, Gaëlle Vandermeulen, Michaela Feodoroff

Front Immunol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines.
Sara Feola, Jacopo Chiaro, Beatriz Martins, Salvatore Russo, Manlio Fusciello, Michaela Feodoroff

Elife· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification.
Sara Feola, Markus Haapala, Karita Peltonen, Cristian Capasso, Beatriz Martins, Michaela Feodoroff

ACS Nano· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids.
Firas Hamdan, Erkko Ylösmäki, Jacopo Chiaro, Yvonne Giannoula, Maeve Long, Michaela Feodoroff

J Immunother Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Derived Organoids for Precision Cancer Immunotherapy.
Mikaela Grönholm, Michaela Feodoroff, Gabriella Antignani, Beatriz Martins, Firas Hamdan

Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses.
Firas Hamdan, Beatriz Martins, Michaela Feodoroff, Yvonne Giannoula, Sara Feola

Mol Ther Methods Clin Dev· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis